Cancer nanotherapies using folate and transferrin receptor mediated nanotherapeutics also allow targeted delivery to tumor cells with significantly reduced damage to nearby cells which were otherwise damaged due to nontargeted conventional chemotherapy [82]. The gene discussed is TFRC; the disease is cancer.